Product Description
Product Name: Faslomax 250 mg Injection
Active Ingredient: Fulvestrant
Strength: 250 mg
Form: Intramuscular Injection
Category: Estrogen Receptor Antagonist / Hormonal Anticancer Agent
Indication: Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women
Faslomax 250 mg Injection contains Fulvestrant, a potent estrogen receptor antagonist used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is particularly indicated in cases where the disease has progressed following anti-estrogen therapy.
